Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 243 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Karagiannis, Asterios [Clear All Filters]
Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?.
Curr Vasc Pharmacol. 14(6), 494-497.
(2016). Editorial: Cardiovascular Disease Mortality Rates are Plateauing in Certain Age Groups and Regions. Can we Keep them Declining?.
Curr Vasc Pharmacol. 14(3), 271-4.
(2016). Editorial: Vascular Calcification, Cardiovascular Risk and microRNAs..
Curr Vasc Pharmacol. 14(2), 208-10.
(2016). Exploring the Management of Statin Intolerant Patients: 2016 and Beyond..
Curr Vasc Pharmacol. 14(6), 523-533.
(2016). Medical students' satisfaction with the Applied Basic Clinical Seminar with Scenarios for Students, a novel simulation-based learning method in Greece..
J Educ Eval Health Prof. 13, 13.
(2016). Off target effects of statins shape total mortality?.
J Drug Assess. 5(1), 4-5.
(2016). PATHWAY-2: spironolactone for resistant hypertension..
Lancet. 387(10026), 1371-1372.
(2016). A Rare Case of Disseminated Pyogenic Gonococcal Infection in an Immunocompetent Woman..
Case Rep Infect Dis. 2016, 9629761.
(2016). Statins and non-alcoholic steatohepatitis..
J Hepatol. 64(1), 241-2.
(2016). Statins and Type 2 Diabetes Mellitus: An Update After 1 Year..
Curr Pharm Des. 22(18), 2723-5.
(2016). Is Targeting microRNAs the Philosopher's Stone for Vascular Disease?.
Curr Vasc Pharmacol. 14(1), 88-97.
(2016).
(2016). Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go..
Angiology. 66(10), 901-3.
(2015). Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update..
World J Gastroenterol. 21(22), 6820-34.
(2015). Cardiovascular Risk in Middle East Populations: A Call to Action..
Angiology. 66(9), 801-2.
(2015). Contrast-Induced Nephropathy: An "All or None" Phenomenon?.
Angiology. 66(6), 508-13.
(2015). Editorial: effect of statins on rates of long-term cardiovascular events and restenosis following carotid endarterectomy..
Curr Vasc Pharmacol. 13(2), 223-5.
(2015). Editorial: microRNAs: Potential Targets for the Treatment of Cardiovascular Disease..
Curr Vasc Pharmacol. 13(3), 366-7.
(2015). Editorial: Statins or Fibrates for the Primary Prevention of Stroke in the Elderly. Faith Makes Some Things Achievable, But Not AII..
Curr Vasc Pharmacol. 13(6), 696-8.
(2015). Genetic, epidemiologic and clinical data strongly suggest that fasting or non-fasting triglycerides are independent cardiovascular risk factors..
Curr Med Res Opin. 31(3), 435-8.
(2015). Health benefits of the Mediterranean Diet: an update of research over the last 5 years..
Angiology. 66(4), 304-18.
(2015). High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus..
J Diabetes Complications. 29(1), 142-5.
(2015). Hyperuricemia as a risk factor for cardiovascular disease..
Expert Rev Cardiovasc Ther. 13(1), 19-20.
(2015). Nonalcoholic fatty liver disease and statins..
Metabolism. 64(10), 1215-23.
(2015). Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome..
World J Gastroenterol. 21(25), 7860-8.
(2015).